Publisher
Springer Nature Switzerland
Reference39 articles.
1. Jaskulski, S., Nuszbaum, C., Michels, K.B.: Components, prospects, and challenges of personalized prevention. Front. Public Health 11, 1075076 (2023). https://doi.org/10.3389/fpubh.2023.1075076
2. Tussié-Luna, M.T., Aguilar-Salinas, C.A.: Precision Medicine for Metabolic Disorders in Low - and Middle - Income Countries: Areas of Opportunity and Challenges for the Future. Rev. Invest. Clin. 73(5), 316–320 (2021). https://doi.org/10.24875/RIC.21000344
3. Drake, T.M., Knight, S.R., Harrison, E.M., Søreide, K.: Global inequities in precision medicine and molecular cancer research. Front. Oncol. 8, 346 (2018). https://doi.org/10.3389/fonc.2018.00346
4. Herold, K.C., et al.: An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N. Engl. J. Med. 381(7), 603–613 (2019). https://doi.org/10.1056/NEJMoa1902226
5. Personalized Medicine Coalition Homepage. https://www.personalizedmedicinecoalition.org/Userfiles/PMCCorprate/file/Personalized_Medicine_at_FDA_The_Scope_Significance_of_Progress_in_2021.pdf
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献